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Abstract
Cardiac paragangliomas are among the rarest primary cardiac tumors. We present a case of left atrial paragan-
glioma in a patient who presented with symptoms and signs of catecholamine excess in which cardiovascular
magnetic resonance in multiple orientations and PET-CT played an important role in the diagnosis and tissue
characterization.
Introduction
Pheochromocytomas or functioning paragangliomas are
catecholamine-producing tumors arising from secretory
chromograffin cells of neuroectodermal origin. These
lesions commonly originate from the adrenal medulla.
Approximately 18% of pheochromocytomas are extra-
adrenal [1].Primary cardiac paragangliomas are extre-
mely rare with less than 50 cases reported in the litera-
ture [2]. Recent advances in cross sectional imaging
have provided the potential for non-invasive and accu-
rate diagnosis of these lesions [3-5]. In this report, we
describe a left atrial paraganglioma, characterized in a
multi-modality setting and confirmed on histopathology.
Case report
A 25-year-old female in her third trimester of preg-
nancy, presented with paroxysmal headache, palpita-
tions, sweating, and hypertension of up to 230/130 for
three weeks. Her medical history was negative for pre-
vious hypertension, and physical examination was unre-
markable. Initial work-up for hypertension excluded
pre-eclampsia. Further biochemistry evaluation revealed
markedly elevated urine catecholamines;
Dopamine 607 μg/24 hours (range 65 - 400), Norepi-
nephrine 978 μg/24 hours (range 15 - 80), Metanephrine
108 μg/24 hours (range 24 - 96), Normetanephrine 4067
μg/24 hours (range 75 - 375), and Vanillyl mandelic acid
13.6 mg/24 hours (range 2 - 7). Epinephrine level was 0.8
μg/24 hours (range 0.0-20.0). A diagnosis of pheochromo-
cytoma was considered and the patient underwent
abdominal magnetic resonance imaging (MRI) which
demonstrated a 28 × 19 mm left juxta-adrenal mass.
Treatment with phenoxybenzamine (10 mg, twice a day)
was initiated. Six weeks following uneventful delivery by
Cesarean Section, the patient underwent left laparoscopic
adrenalectomy for suspected pheochromocytoma. Histo-
pathology showed normal adrenal gland and brown fat in
the juxta-adrenal mass. The patient’s symptoms continued,
and with the suspicion of extra-adrenal pheochromocy-
toma, F
18 Levo-DOPA positron emission tomography-
computed tomography or PET-CT scan of the whole body
was performed to localize the lesion (Siemens Medical
Solutions, Erlangen, Germany). The intravenous F
18 Levo-
DOPA dose was 6.9 mCi, and the patient was pre-medi-
cated with 200 mg of carbidopa 45 minutes before the
scan to enhance the uptake of F
18 Levo-DOPA. On PET-
CT, a large hyper-metabolic soft tissue mass measuring
4.5 × 2.7 × 3.9 cm in the region of posterior mediastinum
near the left atrium was noted (Figure 1, arrow).
Four days following the PET-CT examination, cardio-
vascular MR (CMR) was performed on a 1.5 Tesla MR
scanner (Magnetom Avanto, Siemens Medical Solutions,
Malvern, Pennsylvania, USA) to further characterize the
lesion and its anatomical relation to the atria and sur-
rounding structures. On Steady State Free Precession
(SSFP) breath-hold cine MRI (TE: 1.2 ms, TR: 2.4 ms,
temporal resolution: 40.3 ms), the epicenter of the
hypo-intense soft tissue mass was noted to be in the
posterior mediastinum with no apparent fat plane
between the lesion and the posterior wall of the left
atrium (Figure 2-a, arrow). The mass caused smooth
extrinsic compression of left atrial wall and demon-
strated typical low signal on T1-weighted spin-echo (TE:
* Correspondence: mkrishnam@mednet.ucla.edu
1Department of Radiological Sciences, University of California at Los Angeles,
USA
Tomasian et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:1
http://www.jcmr-online.com/content/12/1/1
© 2010 Tomasian et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.14 ms, TR: 750 ms) and high signal on T2-weighted
dark blood turbo spin-echo (TE: 86 ms, TR: 4000 ms)
images (Figure 2-b).
During administration of 5 mL of gadopentetate dime-
glumine (Magnevist, Berlex Laboratories, Wayne, NJ),
T1-weighted inversion recovery gradient-echo myocardial
perfusion imaging was performed which demonstrated
heterogeneous dynamic contrast filling of the mass (Figure
2-c). In addition, 10 minutes following injection of 0.2
mmol/kg body weight of Magnevist, late gadolinium
enhancement (LGE) CMR was performed using T1-
weighted, fat-saturated, inversion recovery sequence. This
demonstrated peripheral rim enhancement of the mass
with central dark signal suggestive of central tissue necro-
sis (Figure 2-d). Based on clinical history, urine biochemis-
try, and radiological features, a diagnosis of cardiac
paraganglioma, although very rare, was considered. Surgi-
cal procedure was performed through a right anterolateral
thoracotomy, and following cardio-pulmonary bypass, the
tumor was excised. At surgery, the left atrial mural mass
was 4.5 cm in largest dimension originating in the poster-
ior wall with extension to Sondergaard’s groove and inter-
atrial septum. Following excision, left atrial wall and peri-
cardial reconstructions were performed using bovine peri-
cardium and Gore-Tex patch, respectively. Two days after
surgery, 24-hour urine catecholamines returned to normal
range, and following uneventful recovery, the patient was
discharged in stable condition. Histopathologic evaluation
indeed confirmed a cardiac paraganglioma (Figure 3).
The patient remained asymptomatic during the 4-
month follow-up period without local recurrence on
echocardiography.
Figure 1 Axial view of PET-CT scan image demonstrates a
large hypermetabolic mass with intense uptake of F
18 Levo-
DOPA in the posterior mediastinum near the left atrium which
is consistent with paraganglioma.
Figure 2 Horizontal long axis CMR images demonstrate a round, well defined posterior mediastinal mass with smooth extrinsic
compression of left atrial wall which is hypo-intense on breath-hold Steady State Free Precession (SSFP) cine CMR (a, arrow), and
shows homogenously high signal on T2-weighted dark blood turbo spin-echo image (b, arrow). T1-weighted inversion recovery gradient-
echo myocardial perfusion imaging demonstrates heterogeneous, mostly peripheral, dynamic contrast filling of the mass suggesting vascularity
(c, arrow), and T1-weighted, fat-saturated, inversion recovery late gadolinium enhancement image shows peripheral rim enhancement with no
evidence of central enhancement suggestive of central tissue necrosis (d, arrow).
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Primary cardiac tumors are rare with a reported preva-
lence of 0.001% to 0.03% on autopsy series [6]. Of these
tumors, cardiac paragangliomas are among the rarest
accounting for less than 1% of cases [6]. These tumors
originate from paraganglial cells of the arteries or the
visceral autonomic paraganglia of the atria [7]. Cardiac
paragangliomas are most commonly located in the left
atrium [1] and less frequent sites include right atrium,
inter-atrial septum, and the left ventricle [1,4,8]. The
mean age at the presentation is 36-40 years with
approximately equal sex distribution [9]. Cardiac para-
gangliomas are catecholeamine-secreting in 35-50% of
cases [6].
Clinical presentations of cardiac paraganglioma range
from an incidental finding [9] to constitutional symptoms
including malaise, weight loss and fever [3], symptoms
and signs of catecholamine excess (paroxysmal headache,
palpitation, sweating, and hypertension) [1], arrhythmia
due to invasion of the conductive system [4], angina pec-
toris or myocardial infarction secondary to compression
or obstruction of coronary arteries [5], acute heart failure
or dilated cardiomyopathy [10], pericardial involvement,
and disruption of valvular function [4].
The incidence of malignancy is reported to be approxi-
mately 10% [6]. However, there are no histological cri-
teria to differentiate benign from malignant cardiac
paragangliomas [11]. Malignancy is determined by tumor
behavior rather than histological appearance and the dis-
tinguishing feature includes presence of distant metasta-
sis [11]. Histopathologically, paragangliomas are
monomorphous tumors composed of nests of paragan-
glial cells (Zellballen) surrounded by sustentacular cells
[12].
Cardiac paragangliomas are echogenic masses on
echocardiography and are reported as circumscribed,
heterogeneous masses with low attenuation on un-
enhanced CT [14] with marked enhancement on con-
trast enhanced CT [12].
These lesions can be localized using very specific
radiotracers such as
131Io r
123I metaiodobenzylguani-
dine or
18F-DOPA, which are actively transported into
neurosecretory granules of catecholamine-producing
cells [13].
18F-DOPA PET studies have yielded promis-
ing results in the imaging of pheochromocytoma [13],
demonstrating typical intense uptake of
18F-DOPA by
the paraganglional cells of the lesions, as showed in our
case.
Due to its higher spatial resolution and multiplanar
image acquisition, CMR is considered an important
technique in diagnosis and characterization of cardiac
tumors. Cine SSFP and pre-contrast T1- and T2-
weighted imaging are useful for evaluation of anatomic
features, whereas first pass dynamic perfusion and late
gadolinium enhancement sequences are important in
assessment of vascularity.
As seen in our patient, cardiac paragangliomas are
typically iso- or hypo-intense relative to myocardium on
T1-weighted, and markedly hyper-intense on T2-
weighted images [14]. They are highly vascular and as in
our case, may typically demonstrate dynamic contrast
filling on myocardial perfusion imaging which is often
Figure 3 (A) Low power photomicrograph (40×; H&E stain) demonstrates tumor (*) compressing left atrium (LA). (B) The tumor is
comprised of nests of fairly uniform cells with moderate eosinophilic, granular cytoplasm (200×; H&E stain). (C) Marked cytologic atypia with
pleomorphic nuclei and prominent nucleoli was focally present (400×; H&E stain) in addition to (D) increased number of mitoses (arrows) (400×;
H&E stain). (E) Scattered foci of coagulative tumor necrosis (N) were also noted (200×; H&E stain). (F) The tumor exhibited diffuse, strong
cytoplasmic positivity for synaptophysin immunostain (400×). (G) S100 immunostain highlights sustentacular cells surrounding nests of tumor
cells (400×).
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gesting tumor necrosis [14]. Presence of peripheral rim
enhancement on LGE imaging also indicates vascularity
of these lesions distinguishing them from avascular car-
diac masses such as thrombi and lipoma. Although pre-
sence of central dark signal on LGE could be due to
nulling of signal following Inversion pulse, it likely
represents tissue necrosis. Cardiac hemangiomas
demonstrate LGE, intermediate and high signal intensity
on T1 and T2-weighted images, respectively, and show
enhancement on perfusion imaging [12]. Cardiac lym-
phangiomas demonstrate high signal intensity on T1
and T2 weighted images, whereas rhabdomyomas are
isointense on T1 and hyper-intense on T2 weighted
images compared to adjacent myocardium [14].
Surgical resection of cardiac paraganglioma results in
complete cure and relief of symptoms [9,12]. Surgical
risks particular to these lesions include fatal hemorrhage
due to high vascularity, and hypertensive crisis from
intra-operative manipulation which may be avoided by
cardiopulmonary bypass allowing safe dissection. Since
paragangliomas may be infiltrative lesions, as in our
patient, extensive resection of the atrial wall may be
required for complete excision [7].
Conclusion
The combination of CMR with various image acquisi-
tion sequences in multiple orientations and PET-CT
studies, provides a powerful tool for non-invasive mor-
phological assessment and tissue characterization of car-
diac paraganglioma, especially when correlated with
clinical history and appropriate biochemistry
evaluations.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Author details
1Department of Radiological Sciences, University of California at Los Angeles,
USA.
2Department of Pathology, University of California at Los Angeles, USA.
Authors’ contributions
All authors were involved in the conception and design of the manuscript,
acquisition of data, drafting the manuscript, critical revision of the
manuscript for intellectual content, and final approval.
Competing interests
The authors declare that they have no competing interests.
Received: 17 June 2009
Accepted: 4 January 2010 Published: 4 January 2010
References
1. Manger WM: An overview of pheochromocytoma: history, current
concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci 2006,
1073:1-20.
2. Mandak JS, Benoit CH, Starkey RH, Nassef LAJr: Echocardiography in the
evaluation of cardiac pheochromocytoma. Am Heart J 1996, 132:1063-6.
3. Turley AJ, Hunter S, Stewart MJ: A cardiac paraganglioma presenting with
atypical chest pain. Eur J Cardiothorac Surg 2005, 28(2):352-4.
4. Maxey TS, Grow P, Morris CD, Patton KT, Guyton RA: Biatrial primary
cardiac paraganglioma: a rare finding. Cardiovasc Pathol 2007, 16(3):179-
82.
5. Sawka AM, Young WFJr, Schaff HV: Cardiac phaeochromocytoma
presenting with severe hypertension and chest pain. Clin Endocrinol 2001,
54(5):689-92.
6. Burke A, Virmani R: Tumors of the heart and great vessels. Atlas of tumor
pathology. 3rd series, fascicle 16 Washington, DC: Armed Forces Institute of
Pathology 1996.
7. Orringer MB, Sisson JC, Glazer G, et al: Surgical treatment of cardiac
pheochromocytomas. J Thorac Cardiovasc Surg 1985, 89:753-757.
8. Cane ME, Berrizbeitia LD, Yang SS, Mahapatro D, McGrath LB:
Paraganglioma of the interatrial septum. Ann Thorac Surg 1996,
61(6):1845-7.
9. Jebara VA, Uva MS, Farge A, et al: Cardiac pheochromocytomas. Ann
Thorac Surg 1992, 53(2):356-61, Review..
10. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons DO:
Phaeochromocytoma and catecholamine induced cardiomyopathy
presenting as heart failure. Br Heart J 1990, 63:234-7.
11. Nomura A, Kakinoki S, Fujita M, Kitabatake A: Images in cardiovascular
medicine. Malignant cardiac pheochromocytoma with bone metastases.
Circulation 1998, 97(19):1993-4.
12. Grebenc ML, Rosado de Christenson ML, Burke AP, et al: Primary Cardiac
and Pericardial Neoplasms: Radiologic-Pathologic Correlation.
Radiographics 2000, 20:1073-1103.
13. Hoegerle S, Nitzsche E, Altehoefer C, et al: Pheochromocytomas: detection
with18F DOPA whole body PET-initial results. Radiology 2002, 222:507-
512.
14. Araoz PA, Mulvagh SL, Tazelaar HD, Julsrud PR, Breen JE: CT and MR
imaging of benign primary cardiac neoplasms with echocardiographic
correlation. Radiographics 2000, 20(5):1303-1319.
doi:10.1186/1532-429X-12-1
Cite this article as: Tomasian et al.: Cardiovascular magnetic resonance
and PET-CT of left atrial paraganglioma. Journal of Cardiovascular
Magnetic Resonance 2010 12:1.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Tomasian et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:1
http://www.jcmr-online.com/content/12/1/1
Page 4 of 4